Our story began in 1919, when English-born pharmacist and chemist Frederick Alfred Upsher Smith started a company to refine digitalis. Working from a laboratory in downtown Minneapolis, his innovations helped thousands of people struggling with cardiac disease.
More than 100 years later, we at Upsher-Smith Laboratories, LLC are still carrying out our original founder’s commitment to help improve the health and lives of patients. We offer a broad array of generic and branded medications, and our portfolio continues to grow. We know that our customers have many options to choose from in the marketplace, but we believe they repeatedly choose us because we go above and beyond—striving for uninterrupted supply, quick delivery and in-depth account and patient knowledge.
Having celebrated our centennial anniversary in 2019, Upsher-Smith continues to grow in its reputation as a trusted U.S. pharmaceutical company.
Upsher-Smith is a respected and admired member of the healthcare business community and has been for many, many years.
At Upsher-Smith, we support charitable contributions made to non-profit, tax-exempt professional or patient organizations.
We operate in accordance with high ethical standards and a strict code of business conduct. We also strive for corporate compliance in everything we do.
Our Executive Team is comprised of leaders who reflect the values from both Upsher-Smith and our owner, Sawai Group Holdings Co., Ltd.